Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 23, 2013
Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cordEllen C Dengler, Juewen Liu, Audra Kerwin, et al.
Frontiers in Neuroscience|June 26, 2023
Prenatal alcohol exposure dysregulates spinal and circulating immune cell circular RNA expression in adult female rats with chronic sciatic neuropathyShahani Noor, Ariana N Pritha, Andrea A Pasmay, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2009
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic painLisa C Loram, Jacqueline A Harrison, Evan M Sloane, et al.
Pain|August 4, 2004
HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS)Adelina Holguin, Kevin A O'Connor, Joseph Biedenkapp, et al.
Brain, Behavior, and Immunity|December 19, 2006
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in ratsAnnemarie Ledeboer, Brian M Jekich, Evan M Sloane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphomaD C Linch, P Smith, B W Hancock, et al.
The European Journal of Neuroscience|May 5, 2005
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10Erin D Milligan, Stephen J Langer, Evan M Sloane, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC)R Advani, G Visani, D Milligan, et al.
Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.
Neuroimmunology and Neuroinflammation|November 26, 2019
LFA-1 antagonist (BIRT377) similarly reverses peripheral neuropathic pain in male and female mice with underlying sex divergent peripheral immune proinflammatory phenotypesShahani Noor, Melody S Sun, Arden G Vanderwall, et al.
Pageof 18